(Q43780444)

26 November 2017

title

Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men. (English)

1 reference

26 November 2017

Kwanjin Park

1

1 reference

26 November 2017

Jeong H Kim

2

1 reference

26 November 2017

Hwang G Jeon

3

1 reference

26 November 2017

Seok S Byun

4

1 reference

26 November 2017

Eunsik Lee

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

29 March 2010

1 reference

26 November 2017

1 reference

26 November 2017

volume

75

1 reference

26 November 2017

issue

6

1 reference

26 November 2017

page(s)

1516.e1-7

1 reference

Estimates of the worldwide incidence of 25 major cancers in 1990.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Heredity and prostate cancer: a study of World War II veteran twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Evidence for autosomal dominant inheritance of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Autosomal dominant inheritance of prostate cancer: a confirmatory study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Promoter -202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

No association between genetic polymorphisms in insulin and insulin receptor substrate-1 and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Signalling pathways involved in antiproliferative effects of IGFBP-3: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.08.023

10.1016/J.UROLOGY.2009.08.023

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference